We are live on ! Find out more
MSA

Mason Street Advisors Portfolio holdings

AUM $1.02B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+3.03%
1 Year Est. Return
+8.35%
3 Year Est. Return
+28.33%
5 Year Est. Return
+14.8%
10 Year Est. Return
+178.9%
AUM
$4B
AUM Growth
+$102M
Cap. Flow
+$13M
Cap. Flow %
0.33%
Top 10 Hldgs %
13.61%
Holding
1,543
New
26
Increased
1,322
Reduced
163
Closed
28

Top Buys

Rank Stock Value
1
DXC icon
DXC Technology
DXC
+$3.02M
2
JHG
Janus Henderson
JHG
+$2.88M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$2.57M
4
VVV icon
Valvoline
VVV
+$2.31M
5
SABR icon
Sabre
SABR
+$2.29M

Sector Composition

Rank Sector Weight
1 Financials 15.78%
2 Technology 14.91%
3 Healthcare 12.82%
4 Industrials 11.52%
5 Consumer Discretionary 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPPI
1401
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$130K ﹤0.01%
17,450
+873
+5% +$5.7K
LNTH icon
1402
Lantheus
LNTH
$6.6B
$129K ﹤0.01%
+7,283
New +$107K
MYRG icon
1403
MYR Group
MYRG
$5.16B
$126K ﹤0.01%
4,063
+306
+8% +$10.5K
SAH icon
1404
Sonic Automotive
SAH
$2.68B
$126K ﹤0.01%
6,503
+357
+6% +$6.8K
VRTV
1405
DELISTED
VERITIV CORPORATION
VRTV
$125K ﹤0.01%
2,785
+100
+4% +$4.59K
BKE icon
1406
Buckle
BKE
$2.36B
$124K ﹤0.01%
6,987
+393
+6% +$7.01K
LDR
1407
DELISTED
Landauer Inc
LDR
$124K ﹤0.01%
2,377
+127
+6% +$6.54K
EGL
1408
DELISTED
Engility Holdings, Inc.
EGL
$124K ﹤0.01%
4,353
+225
+5% +$6.27K
ENTA icon
1409
Enanta Pharmaceuticals
ENTA
$388M
$123K ﹤0.01%
3,427
+178
+5% +$5.69K
ARCB icon
1410
ArcBest
ARCB
$3.02B
$122K ﹤0.01%
5,925
+356
+6% +$7.72K
FTK icon
1411
Flotek Industries
FTK
$1.32B
$120K ﹤0.01%
2,236
+125
+6% +$7.87K
HVT icon
1412
Haverty Furniture Companies
HVT
$450M
$120K ﹤0.01%
4,764
+250
+6% +$6.09K
LION
1413
DELISTED
Fidelity Southern Corporation
LION
$120K ﹤0.01%
5,264
+313
+6% +$6.92K
AMRI
1414
DELISTED
Albany Molecular Research Inc
AMRI
$119K ﹤0.01%
5,505
+290
+6% +$5.26K
PGNX
1415
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$118K ﹤0.01%
17,318
+938
+6% +$6.92K
HZO icon
1416
MarineMax
HZO
$776M
$117K ﹤0.01%
6,005
+329
+6% +$6.44K
UFI icon
1417
UNIFI
UFI
$128M
$116K ﹤0.01%
3,775
+200
+6% +$5.65K
MED icon
1418
Medifast
MED
$136M
$115K ﹤0.01%
2,765
+161
+6% +$7K
ACET
1419
DELISTED
Aceto Corp
ACET
$115K ﹤0.01%
7,423
+380
+5% +$5.67K
CRVL icon
1420
CorVel
CRVL
$3.19B
$114K ﹤0.01%
7,218
+375
+5% +$5.68K
SUP
1421
DELISTED
Superior Industries International
SUP
$114K ﹤0.01%
5,528
+280
+5% +$5.82K
HAYN
1422
DELISTED
Haynes International, Inc.
HAYN
$112K ﹤0.01%
3,085
+160
+5% +$6.02K
AVD icon
1423
American Vanguard Corp
AVD
$73.5M
$111K ﹤0.01%
6,463
+422
+7% +$7.27K
CMTL icon
1424
Comtech Telecommunications
CMTL
$51.5M
$110K ﹤0.01%
5,808
+307
+6% +$4.75K
WRLD icon
1425
World Acceptance Corp
WRLD
$886M
$110K ﹤0.01%
1,474
+76
+5% +$5.2K

Similar funds

Mason Street Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Mason Street Advisors held 1,543 positions worth $4B, up 2.6% from $3.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 3.5%. Mason Street Advisors opened 26 new positions and exited 28, leaving the 1,543-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

  • Mason Street Advisors's largest Q2 2017 buy was DXC Technology: 45,431 shares worth $3.02M.
  • Mason Street Advisors added most to iShares Russell 2000 ETF in Q2 2017, an estimated $2.57M increase.
  • Mason Street Advisors's biggest Q2 2017 reduction was iShares Russell Mid-Cap ETF, cutting an estimated $13.5M.
  • Mason Street Advisors fully exited Yahoo Inc in Q2 2017, selling an estimated $5.63M.
  • Mason Street Advisors's ten largest holdings make up 14% of its $4B portfolio in Q2 2017.
  • Mason Street Advisors opened 26 new positions and closed 28 in Q2 2017.
  • Mason Street Advisors's portfolio value rose 2.6% quarter-over-quarter to $4B.

Based on Mason Street Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.